Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zackrisson

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Scandinavian Journal of Rehabilitation Medicine. Supplement|January 1, 1983
A short report from the project "Improved communication aids for people with speech impediments"E Björck-Akesson, I Hjort, U Lagerman, et al.
Journal of Clinical Microbiology|March 21, 1998
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infectionsL Lind-Brandberg, C Welinder-Olsson, T Lagergård, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
The Journal of Pediatrics|April 1, 1990
Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old childrenI Krantz, R Sekura, B Trollfors, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
The Journal of Pediatrics|April 1, 1997
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussisB Trollfors, J Taranger, T Lagergård, et al.
The New England Journal of Medicine|October 19, 1995
A placebo-controlled trial of a pertussis-toxoid vaccineB Trollfors, J Taranger, T Lagergård, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2001
Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated personsJ Taranger, B Trollfors, E Bergfors, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Scandinavian Journal of Rehabilitation Medicine. Supplement|January 1, 1983
A short report from the project "Improved communication aids for people with speech impediments"E Björck-Akesson, I Hjort, U Lagerman, et al.
Journal of Clinical Microbiology|March 21, 1998
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infectionsL Lind-Brandberg, C Welinder-Olsson, T Lagergård, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
The Journal of Pediatrics|April 1, 1990
Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old childrenI Krantz, R Sekura, B Trollfors, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
The Journal of Pediatrics|April 1, 1997
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussisB Trollfors, J Taranger, T Lagergård, et al.
The New England Journal of Medicine|October 19, 1995
A placebo-controlled trial of a pertussis-toxoid vaccineB Trollfors, J Taranger, T Lagergård, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2001
Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated personsJ Taranger, B Trollfors, E Bergfors, et al.
Pageof 3